Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback